ĐẶC ĐIỂM CÁC CHỈ SỐ XÉT NGHIỆM TỔNG PHÂN TÍCH TẾ BÀO MÁU NGOẠI VI TRÊN BỆNH NHÂN COPD

Abstract

Objective: Description of laboratory indicators of total blood count in patients with COPD. Method: cross-sectional description of the total analysis of peripheral blood cells of COPD patients at Thai Nguyen Central Hospital's Blood Transfusion Hematology Center from June 2022 to May 2023. Results: leukocyte flow: the proportion of patients with a leukocytosis count is 70.25%; leukopenia is 4.25%; patients with increased NE white blood cell count accounted for 78.74%, increased MO accounted for 82.97% and a small number of patients had an increased EO white blood cell count accounted for 8.51%, increased BA accounted for 6.38%. Platelet flow: thrombocytosis is 6.38%; thrombocytopenia was 8.51%. Red blood cell line: the mean red blood cell count of patients was 4.51±0.60 T/L, HGB was 132.56±17.22 g/L; HCT is 40.24±4.88 L/L; MCV is 89.10±6.99 fL; MCH is 29.50±2.64 pg; MCHC is 329.30±13.45; RDW is 14.32±1.28%, the prevalence of mild anemia is 21.28% and in other levels of anemia it is 0%. Conclusion: In patients with COPD, most have changes in white blood cell line index, red blood cell line and platelet count is little changed.